Biotechnology News

August 8, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that Palmetto GBA, a national contractor that administers Medicare benefits, has established coverage for the...

August 8, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals reports record revenues and strong profits for second quarter 2012.

August 8, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics (NYSE MKT: IMUC) announced today that clinical data from its Phase I trial of ICT-107 was accepted for publication, and is currently in the online edition of the prestigious medical...

August 8, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today reported financial and operating results for the second quarter ended June 30, 2012. Quarter and Recent Highlights Completed the VIBEX™ MTX Actual Human Use study. Results...

August 8, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Wedbush 2012 Life Sciences Management Access Conference in New York on Tuesday, August 14, 2012 at...

August 8, 2012

LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (Nasdaq: CBRX) today reported financial results for the three- and six- month periods ended June 30, 2012. Highlights of the second quarter include: Net product revenues were $7.4...

August 8, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) today provided a Company update and reported financial results for the second quarter of 2012. “We continue to make progress on our late stage clinical programs. We are enrolling our two...

August 8, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ:CLVS) today reported financial results for the second quarter 2012, and provided an update on the progress of its clinical development programs and expected milestones for the rest of...

August 8, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Fast-growing APCER Pharma has a new website that emphasizes its expertise and global capabilities for outsourced clinical safety, pharmacovigilance, medical affairs and regulatory compliance.

August 8, 2012

GENEVA & ARCHAMPS, France--(BUSINESS WIRE)--Genkyotex and collaborators publish data in Hepatology showing activity of lead NOX inhibitor GKT137831 in models of fibrosis.

August 8, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--The 2012 Heinrich Emanuel Merck Award for Analytical Science will be given to Professor Wheeler from the University of Toronto.

August 8, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac, leading experts in the management of temperature controlled clinical supplies, has further enhanced its service offering with the completed expansion of refrigerated (2-8°C) storage and newly...

August 7, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

August 7, 2012

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall’s 2011-12 Lab Products Catalog is now available in an easy-to-use, interactive digital format, as well as a downloadable app (Pall Lab Catalog) for iPhone®, iPad® and iPod® from the App StoreSM.

August 7, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories reports second-quarter 2012 financial results

August 7, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is scheduled to present at the Canaccord Genuity Annual Growth Conference in Boston on Tuesday, August 14, 2012 at 8:30 a.m. ET and the Wedbush Securities Life Sciences...

August 7, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. Reports Second Quarter and Six Months 2012 Financial and Operating Results

August 7, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the second quarter and six months ended June 30, 2012. “...

August 7, 2012

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, today reported financial and operating results for the quarter ended June 30, 2012. Key financial results include: Total revenues of $47.2 million...

August 7, 2012

RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo BioSciences’s CEO, Edward Lanphier, will update on the company's ZFP Therapeutic® development programs at the upcoming 2012 Wedbush PacGrow Lifesciences Conference next week.

August 7, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the second quarter and six months ended June 30, 2012. Revenues for the second quarter were $10.4 million, compared to $37.4 million for the...

August 7, 2012

SAN MATEO, Calif.--(BUSINESS WIRE)--Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company, today announced financial and business results for the quarter ended June 30, 2012. Maxygen also announced today that its Board of Directors has authorized...

August 7, 2012

AMSTERDAM, The Netherlands--(BUSINESS WIRE)--Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today reported its financial results for the second quarter of...

August 7, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics Reports Second Quarter 2012 Results

August 7, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the second quarter ended June 30, 2012.

August 7, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) today announced more than 100 speakers covering the latest in industrial biotechnology at the 2012 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. The Summit...

August 7, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Most proxy-related assessments of executive pay programs are not well-suited to the business and mission of many biotech firms, according to Pearl Meyer & Partners.

August 7, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) announces the 2nd annual BIO Convention in China will take place October 24-25, 2012 in Shanghai, China.

August 7, 2012

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management and Primeum today announced that they have formed a joint venture to globally deploy the Primeum incentive and compensation solution through the Cegedim cloud infrastructure, with the...

August 7, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix issued key patent for ultra-sensitive digital immunoassay platform

August 7, 2012

ZURICH & HAMBURG--(BUSINESS WIRE)--BIO-Europe® 2012 to be held in Hamburg, Germany; “Gateway to the Nordic region” is ripe for dealmaking

August 7, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Results of landmark SWITCH study published, showing that TB blood tests are cost saving for screening health care workers

August 7, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research has entered an exclusive partnership with Gallus BioPharmaceuticals.

August 7, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Shared savings collaborative launched by the Premier healthcare alliance to help ACOs with Medicare applications

August 7, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials will update investors at the 2012 Canaccord Genuity Growth...

August 7, 2012

CLEVELAND--(BUSINESS WIRE)--Cleveland HeartLab, a specialty laboratory and cardiovascular disease management company, announced that its annual symposium will focus on the heart-brain connection and its relationship to wellness.

August 7, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Online Tech Announces Fall into IT Seminar at Ann Arbor Data Center; Seminar Topics to Include BYOD, mHealth, Mobile Apps, Security, Compliance

August 7, 2012

DAVIS, Calif.--(BUSINESS WIRE)--Simplify clinical diagnosis of autoimmune disease. FIDIS multiplex product suite: up to 13 results in a single well, reduced labor and overhead, increased throughput, small sample volume & automatino

August 7, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics has selected its lead candidate for the treatment of fatty liver disease with advanced fibrosis. Clinical trials are expected to begin in early 2013.

August 7, 2012

BOSTON--(BUSINESS WIRE)--The Harvard Clinical Research Institute announced today the successful completion of randomization into the DAPT Study, with the total number of patients randomized exceeding the upper goal set.

August 7, 2012

LOS ANGELES--(BUSINESS WIRE)--FIDELIS DIAGNOSTICS PARTNERS WITH EXALENZ BIOSCIENCE TO ADD H. PYLORI BREATH TESTING SOLUTIONS TO ITS PORTFOLIO OF SERVICES

August 7, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for operating room basins

August 7, 2012

WASHINGTON--(BUSINESS WIRE)--Kelley Bernheim Dolinsky, LLC, a national consumer safety law firm specializing in dangerous pharmaceutical litigation -- www....

August 7, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Today, an equal 29% of companies align their HEOR teams under market access, while the remaining surveyed companies house HEOR under clinical research and development, marketing or other departments...

August 7, 2012

TORONTO--(BUSINESS WIRE)--Functional Neuromodulation begins study of deep brain stimulation for Alzheimer's Disease.

August 7, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus (NASDAQ: CERS) announced today its distributor for Turkey has signed an agreement with the Florence Nightingale Hospital of Turkey, to supply the INTERCEPT Blood System for platelets & plasma.

August 7, 2012

SAN DIEGO--(BUSINESS WIRE)--SNMX 2Q12 Results: Development activities for new S52617 High Fructose Corn Syrup (HFCS) & sucrose modifier; international regulatory approvals. Call today 11am EST; audio at IR tab,...

August 7, 2012

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will present an update on its primary drug candidate, neratinib, at the Wedbush PacGrow Life Sciences Conference on August 14.